| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3846 |
| Trial ID | NCT06361745 |
| Disease | Systemic Lupus Erythematosus | Idiopathic Inflammatory Myopathy | Systemic Sclerosis |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | UTAA09 |
| Phase | Not Applicable |
| Recruitment status | Recruiting |
| Title | Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory |
| Year | 2024 |
| Country | China |
| Company sponsor | PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
| Other ID(s) | PG-005-6 |
| Cohort 1 | |||||||||||
|
|||||||||||